EP2958615B1 - Catheter for administering active agents - Google Patents
Catheter for administering active agents Download PDFInfo
- Publication number
- EP2958615B1 EP2958615B1 EP14714351.5A EP14714351A EP2958615B1 EP 2958615 B1 EP2958615 B1 EP 2958615B1 EP 14714351 A EP14714351 A EP 14714351A EP 2958615 B1 EP2958615 B1 EP 2958615B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- tubular element
- catheter
- flexible
- outer tubular
- catheter according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000013543 active substance Substances 0.000 title claims description 27
- 239000000463 material Substances 0.000 claims description 9
- 239000003550 marker Substances 0.000 claims description 6
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 claims description 3
- 229910001000 nickel titanium Inorganic materials 0.000 claims description 3
- 230000035515 penetration Effects 0.000 claims description 3
- 238000007789 sealing Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 description 15
- 229940079593 drug Drugs 0.000 description 15
- 230000003902 lesion Effects 0.000 description 11
- 238000002399 angioplasty Methods 0.000 description 8
- 239000007788 liquid Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 230000000087 stabilizing effect Effects 0.000 description 5
- 238000005452 bending Methods 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000004351 coronary vessel Anatomy 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002966 stenotic effect Effects 0.000 description 3
- 231100001012 cardiac lesion Toxicity 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 208000037803 restenosis Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 208000037804 stenosis Diseases 0.000 description 1
- 230000036262 stenosis Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M25/0054—Catheters; Hollow probes characterised by structural features with regions for increasing flexibility
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
- A61M25/0082—Catheter tip comprising a tool
- A61M25/0084—Catheter tip comprising a tool being one or more injection needles
- A61M2025/0089—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip
- A61M2025/009—Single injection needle protruding axially, i.e. along the longitudinal axis of the catheter, from the distal tip the needle having a bent tip, i.e. the needle distal tip is angled in relation to the longitudinal axis of the catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1047—Balloon catheters with special features or adapted for special applications having centering means, e.g. balloons having an appropriate shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1079—Balloon catheters with special features or adapted for special applications having radio-opaque markers in the region of the balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0266—Shape memory materials
Definitions
- the present description relates to catheters.
- Various embodiments can relate to catheters for administering active agent, for example, for administering medication to a tissue lesion.
- PTA Percutaneous Transluminal Angioplasty
- DES Drug Eluting Stent
- Balloon catheters capable of delivering an active agent, such as a drug are known for other means, thanks to the fact that the wall of the balloon is provided with openings (or rather is “porous"). These openings allow a liquid placed inside the balloon itself to spread to the outside of the balloon, which serves as a liquid carrier for the active agent.
- the liquid in question may be the pressurized liquid used for dilating the balloon on the site subjected to treatment.
- catheters have been proposed for administering - by injection - a drug suitable for treating a tissue lesion, for example, a blood vessel or a tissue that is located in the vicinity of a blood vessel as demonstrated in the documents US-A-2007/0282257 , WO-A-2012/029535 , US-A-5 354 279 , US-A-2011/0166516 , US-A-5 693 029 and US-A-2003/0171714 .
- a drug suitable for treating a tissue lesion for example, a blood vessel or a tissue that is located in the vicinity of a blood vessel as demonstrated in the documents US-A-2007/0282257 , WO-A-2012/029535 , US-A-5 354 279 , US-A-2011/0166516 , US-A-5 693 029 and US-A-2003/0171714 .
- the catheter described in US-A-2003/017174 presents, however, a relatively complex configuration for the expulsion of the needle from the catheter body, where it is the structure of the catheter body that determines the acquisition of the curvature required by the needle for the injection of the drug into the lesion.
- Various embodiments aim to provide a catheter suitable for administering an active agent to a body site, for example, for administering a drug to a deep lesion in a tissue, the catheter having a simple structure and being economically more advantageous to produce.
- a percutaneously-insertable catheter for administering an active agent to a body site comprising:
- the flexible element may comprise an outer tubular element and an inner tubular element inserted into the outer tubular element, with one of said outer tubular element and said inner tubular element having notches, which allow the spinal column-like curvature towards said body site.
- Various embodiments exemplified here may enable the administering of an active agent, such as a drug in either liquid form for a rapid uptake, or in gel-form to obtain a slower release profile, which is controlled by the lesion.
- an active agent such as a drug in either liquid form for a rapid uptake, or in gel-form to obtain a slower release profile, which is controlled by the lesion.
- an embodiment in the context of this description indicates that a particular configuration, structure or characteristic described in relation to the embodiment is included in at least one embodiment. Therefore, phrases such as “in an embodiment”, possibly present in various points of this description do not necessarily refer to the same embodiment. Furthermore, particular conformations, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
- Figures 1 and 2 to 4 show, respectively, a side view and a series of cross-sectional views of a catheter 10, which can be used to administer an active agent to a body site, for example, to administer a drug to a tissue lesion.
- the catheter 10 can include a body 12 provided at its distal end 2 with a flexible (curvable) element 16 for administering an active agent (e.g. a drug, reagent, etc.) and an expandable portion 22, on a distal portion of the catheter 10, capable of being expanded between a contracted position and a deployed position.
- an active agent e.g. a drug, reagent, etc.
- the expandable portion 22 can comprise an expandable balloon.
- a guide wire 14 can be associated with the catheter 10, along its entire length.
- the active agent e.g. drug
- the active agent can be supplied in liquid form, or as a gel, to the flexible element 16 through a supply lumen 18a, which extends within the body 12 of the catheter, and is connected - at the proximal end 6 of the catheter 10 - by means of a luer fitting 13 - to a system for supplying and pressurising the active agent to be administered (not visible in the figures, and of known type).
- the supply lumen 18a can be housed within an inner tubular sheath 122, which extends within the internal body 12 of the catheter 10.
- the expandable portion (balloon) 22 is inflatable thanks to a fluid made to flow through a supply inlet 4 positioned at the proximal end 6 of the catheter itself, through an inflation lumen 18b, by a system for supplying and pressurising the inflation fluid (not visible in the figures, and of known type).
- the guide wire 14 and/or the flexible element 16 can be movable relative to the body 12 in the longitudinal direction.
- the flexible element 16 can be free to rotate around its own axis, thanks to a rotation system (not visible in the figures, and of known type) positioned at the proximal end of the catheter 10.
- the body 12 can have a third lumen 18c for sliding the guide wire 14.
- the three lumen 18a, 18b and 18c, and the inner tubular sheath 122 can extend longitudinally within the body 12 of the catheter and/or be independent of each other.
- the body 12 of the catheter 10 can have a diameter and a length so that they can be inserted into a blood vessel of the femoral region or of the brachial region of a human body, so as to carry the distal end of the catheter 10 to the area where the administering of an active agent is required, for example to the heart (percutaneous insertion).
- the body 12 of the catheter can be created with a flexible material so that it can also be inserted into a tortuous blood vessel.
- a radiopaque element 171 (e.g. of platinum) can be associated with the distal end 2 of the catheter 10, having the function of terminal marker to allow the operator - by means of scopy - to appropriately orient the catheter 10 itself.
- the expandable portion (balloon) 22 can be used to stabilize the distal end 2 of the catheter in order to enable the flexible element 16 to penetrate into the vessel wall to inject the active agent supplied through the conduit 18a.
- the element 16 is capable of acting by flexible needle (curvable) for administering, in practice by injecting it in the site to be treated (e.g. into a tissue lesion), the active agent (drug, reagent, etc.) supplied through conduit 18a.
- this stabilizing function of the flexible element (needle) 16 can be conducted in addition to, or alternatively to, using the balloon 22 for carrying out angioplasty.
- the flexible element 16 can comprise a (first) outer tubular element 161 and a (second) inner or core tubular element 167 arranged within the first tubular element 161 and capable of receiving the active agent to be administered from the conduit 18a.
- the outer tubular element 161 can comprise a (super)elastic metallic material, such as Nitinol, while the inner or core tubular element 167 can comprise an flexible synthetic material (such as a polyamide resin or polyethylene).
- a (super)elastic metallic material such as Nitinol
- an flexible synthetic material such as a polyamide resin or polyethylene
- the first tubular element 161 can be provided with, on a portion of its lateral surface, a sequence of notches or slots 163, capable of allowing the flexible element 16 to become curved with a jointed configuration, roughly definable as "spinal column-like.”
- the first tubular element 161 can comprise a plurality of open or closed sections or tubular segments ("vertebrae"), connected - at the bottom parts of the notches 163 - by flexible bridges 169 that enable bending of the element 161 itself.
- verbrae open or closed sections or tubular segments
- the element 161 comprises a single piece of flexible material (e.g. an elastic or superelastic material such as nitinol)
- the tubular shape causes the aforementioned sections or segments to become rigid, or essentially rigid, with respect to bending in the longitudinal direction, and in any case, less flexible relative to the bridges 169 connecting them, these bridges 169 identifying the regions of longitudinal bending of the element 161.
- the first tubular element 161 (and therefore the element 16 as a whole, thanks to the overall flexibility of the core element 167) can thus achieve, after extraction from the catheter 10, an overall curved configuration in order to allow its penetration at the site (e.g. injured tissue) to be treated.
- the flexible element 16 can present a sharp tip part (for example a chamfer cut 165 at the distal opening of the first tubular element 161), capable of facilitating the penetration of the flexible element 16 into the treated site.
- a sharp tip part for example a chamfer cut 165 at the distal opening of the first tubular element 161
- the notches 163 in the first tubular element 161 can be produced by means of laser technology and/or can generally present a V-profile.
- the notches 163 can be:
- the notches 163 can be, for example:
- the profile imparted to the notches 163 may enable the determining of the final trajectory of curvature, which may be reached when the notches located on the intrados of the arc of curvature are "closed", with the opposite sides of the notch nearer to each other.
- the secondo tubular element 167 can act as an internal core that closes the notches 163 present on the first tubular element 161; the active agent can then flow within the element 16 to be released (injected) at the site to be treated, avoiding dispersion within the vessel (e.g. blood) where the catheter has been inserted.
- the vessel e.g. blood
- At least one radiopaque element 170 e.g. platinum
- the at least one trajectory marker of curvature 170 can be placed alongside at least one of said notches, for example in correspondence with at least one of the bridges 169.
- a plurality of trajectory markers of curvature 170 may be associated with the flexible element 16, and arranged alongside said notches 163.
- the flexible element 16 - straight or essentially straight when it is received within the body 12 of the catheter - is therefore able, once extracted from the inner tubular sheath 122 (and therefore no longer contained radially by the inner tubular sheath 122 itself), to become curved, or rather to take a general comma-shape.
- this result can be achieved, for example, when either one or the other, or both, of the outer tubular element 161 and the inner tubular element 167 presents the aforesaid curved conformation as "rest" configuration, or rather, a configuration where either one or the other, or both of these elements 161 and 167 return elastically when no longer contained by the inner tubular sheath 122 of the catheter.
- a similar result can be achieved, when either one or the other, or both, of the outer element 161 and the inner element 167 present characteristics of shape-memory, activatable for example by administering energy (e.g. thermal or electrical) in order to carry the element 16 into the curved condition for administering the active agent.
- energy e.g. thermal or electrical
- the action of containment by the inner tubular sheath 122 of the catheter in order to maintain the element 16 in a straight condition, or essentially straight (not curved) may be unnecessary, so that it may be superfluous to envisage that the element 16 is initially sheathed and then left uncovered when curving of the element 16 is required.
- the structure and/or constituent materials exemplified herein allow a remote torsional control of the element 16, starting from the proximal end of the catheter (kept outside the patient's body) so as to enable rotation of the flexible element 16 about the main axis of the distal portion of the catheter (e.g. the axis of the balloon 22) to ensure administration of the active agent at the treated site.
- this result can be achieved by rotating even just one of the elements 161 or, respectively, 167 (having the capacity to curve - e.g. elastically and/or by shape-memory - in a determined direction) while the other element 167 or, respectively, 161 follows the first, thanks to a general flexibility.
- the roles of the elements 161 and 167 could be reversed with respect to what has been previously described, also without prejudice to the other characteristics previously illustrated, for example by providing the notches 163 (and therefore the flexible spinal column structure) on the inner element 167, with the outer element 161 forming a sheath or flexible coat capable of wrapping the inner element, ensuring a seal at the notches 163, which prevents leakage of the active agent through these notches.
- the method of use of the catheter exemplified here envisages that the catheter 10 is introduced into the body of the patient according to current modes, for example, through the femoral artery, and guided until the distal portion is located at the site to be treated (by way of example, an area of the neo-infarcted heart).
- the introduction of the catheter is carried out with the balloon in the radially-contracted condition (i.e. with the balloon 22 "deflated", e.g. wrapped on the distal portion of the catheter).
- the inflation fluid is introduced under pressure into the lumen 18b, causing the balloon 22 to inflate, expanding radially, for example as shown in Figure 5 , stabilizing the distal end of the catheter 10.
- the flexible element 16 can be then made to exit from the body 12 of the catheter, so that the element 16 assumes, according to the criteria described above, the curved conformation exemplified in Part B of Figure 5 .
- the element 16 can be oriented in such a way to allow it to penetrate into the site (e.g. tissue lesion) to be treated.
- the active agent is then supplied to the flexible element 16 through the lumen 18a, in order to carry out its function.
- the catheter 10 described herein is usable for percutaneous procedures intended to reach not only the coronary arteries, but also all the reachable areas through the vascular system where it may be necessary to release an active agent, e.g. a drug to treat a lesion adjacent to a vessel.
- an active agent e.g. a drug to treat a lesion adjacent to a vessel.
- the active agent e.g. the drug
- a colloidal dispersion for example, a gel with a viscosity of up to 200-300 cP
- the stabilizing procedure of the distal portion of the catheter by the balloon 22 can take into account possible critical aspects of blood flow in the area. For example for stabilizing the catheter in the coronary arteries, it is possible to limit the inflation time of the balloon so as not to induce undesired side effects of cardiac ischemia.
- the stabilizing balloon 22 can be mounted on the distal part of the catheter so that its axis is not aligned with that of the catheter body, so as to favor the convergence of the flexible element to the vessel wall and, consequently, to the site to be treated.
- the system of reaching the position of release of the active agent can be configured as in the case for systems used for angioplasty, in which the tip of the catheter is directed with a guide catheter so that it can cross particular passages, such as the coronary ostia, with the catheter made to follow beyond the ostia up to the coronary artery, making it follow a guide wire that reaches the required point.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
- The present description relates to catheters. Various embodiments can relate to catheters for administering active agent, for example, for administering medication to a tissue lesion.
- The techniques of Percutaneous Transluminal Angioplasty (PTA) have been well established for years for treating stenotic vessels, such as the coronary arteries. In this context, the importance has been revealed of ensuring that the beneficial effects of the treatment are able to last over time.
- For this reason, in addition to the plain and simple treatments of PTA, based on a sequence of dilatation actions of the stenotic vessel, carried out using a balloon catheter, there has been widespread use of techniques which involve an implant at the stenotic site, of a stent, which is an expandable tubular structure able to produce a support action of the vessel wall in order to permanently preserve the patency conditions achieved/restored with angioplasty.
- The stent implantation does not, however, completely exclude the risk of restenosis phenomena. This has led to the development of a Drug Eluting Stent (DES), capable of releasing an active agent on the treated site, such as a restenosis-antagonist agent.
- Balloon catheters capable of delivering an active agent, such as a drug, are known for other means, thanks to the fact that the wall of the balloon is provided with openings (or rather is "porous"). These openings allow a liquid placed inside the balloon itself to spread to the outside of the balloon, which serves as a liquid carrier for the active agent. In particular, the liquid in question may be the pressurized liquid used for dilating the balloon on the site subjected to treatment.
- Moreover, catheters have been proposed for administering - by injection - a drug suitable for treating a tissue lesion, for example, a blood vessel or a tissue that is located in the vicinity of a blood vessel as demonstrated in the documents
US-A-2007/0282257 ,WO-A-2012/029535 ,US-A-5 354 279 ,US-A-2011/0166516 ,US-A-5 693 029 andUS-A-2003/0171714 . Among other documents of interest one may citeUS 2003/318067 ,US 2013/035609 ,WO 2010/125166 ,WO 00/67832 US 6 692 466 ,WO 2012/151396 ,WO 2004/045672 ,WO 2006/065949 ,US 200/069882 ,US 2007/219464 .
In particular, the U.S. patent applicationUS-A-2003/0171714 , on which the preamble of claim 1 has been patterned, proposes a catheter equipped with a balloon and a needle for administering a drug to a cardiac lesion, where the balloon has the function of retaining the needle in the required position for administering the drug to the cardiac lesion. - The catheter described in
US-A-2003/017174 presents, however, a relatively complex configuration for the expulsion of the needle from the catheter body, where it is the structure of the catheter body that determines the acquisition of the curvature required by the needle for the injection of the drug into the lesion. - Various embodiments aim to provide a catheter suitable for administering an active agent to a body site, for example, for administering a drug to a deep lesion in a tissue, the catheter having a simple structure and being economically more advantageous to produce.
- Various embodiments enable achievement of this objective thanks to a catheter having the characteristics referred to specifically in the claims that follow.
- The claims form an integral part of the technical disclosure herein provided in relation to the invention.
- Various embodiments exemplified here may refer to a percutaneously-insertable catheter for administering an active agent to a body site, the catheter comprising:
- a distal portion expandable from a contracted condition of introduction to a deployed administering condition, to stabilize the distal end of the catheter at said body site, and
- a flexible tubular element coupled to said distal end of the catheter to receive and administer the active agent to said body site.
- In various embodiments, the flexible element may comprise an outer tubular element and an inner tubular element inserted into the outer tubular element, with one of said outer tubular element and said inner tubular element having notches, which allow the spinal column-like curvature towards said body site.
- Various embodiments exemplified here may enable the administering of an active agent, such as a drug in either liquid form for a rapid uptake, or in gel-form to obtain a slower release profile, which is controlled by the lesion.
- Embodiments will now be described, purely by way of non-limiting example, with reference to the attached figures, wherein:
-
Figure 1 shows a catheter according to one embodiment; -
Figures 2 to 4 are sections along the lines II-II, III-III and IV-IV ofFigure 1 , respectively; -
Figure 5 , comprising two parts indicated respectively by A and B, represents an embodiment of a flexible element shown in the retracted condition within the catheter (part A ofFigure 5 ) and in the extracted condition from the catheter (part B ofFigure 5 ) ; -
Figure 6 is a section along the line VI-VI of part A ofFigure 5 ; and -
Figure 7 shows the mode of use of embodiments. - In the following description, various specific details are illustrated, aimed at a thorough understanding of various examples of embodiments. The embodiments can be implemented without one or more of the specific details, or with other methods, components, materials, etc. In other cases, known structures, materials, or operations are not shown or described in detail to avoid obscuring the various aspects of the embodiments.
- The reference to "an embodiment" in the context of this description indicates that a particular configuration, structure or characteristic described in relation to the embodiment is included in at least one embodiment. Therefore, phrases such as "in an embodiment", possibly present in various points of this description do not necessarily refer to the same embodiment. Furthermore, particular conformations, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
- The references used herein are only for the convenience of the reader and therefore do not define the field of protection or the scope of the embodiments.
-
Figures 1 and 2 to 4 show, respectively, a side view and a series of cross-sectional views of acatheter 10, which can be used to administer an active agent to a body site, for example, to administer a drug to a tissue lesion. - In various embodiments, the
catheter 10 can include abody 12 provided at its distal end 2 with a flexible (curvable)element 16 for administering an active agent (e.g. a drug, reagent, etc.) and anexpandable portion 22, on a distal portion of thecatheter 10, capable of being expanded between a contracted position and a deployed position. - In various embodiments, the
expandable portion 22 can comprise an expandable balloon. - In various embodiments, a
guide wire 14 can be associated with thecatheter 10, along its entire length. - In various embodiments, the active agent (e.g. drug) can be supplied in liquid form, or as a gel, to the
flexible element 16 through asupply lumen 18a, which extends within thebody 12 of the catheter, and is connected - at the proximal end 6 of the catheter 10 - by means of a luer fitting 13 - to a system for supplying and pressurising the active agent to be administered (not visible in the figures, and of known type). - In various embodiments, the
supply lumen 18a can be housed within an innertubular sheath 122, which extends within theinternal body 12 of thecatheter 10. - The expandable portion (balloon) 22 is inflatable thanks to a fluid made to flow through a supply inlet 4 positioned at the proximal end 6 of the catheter itself, through an
inflation lumen 18b, by a system for supplying and pressurising the inflation fluid (not visible in the figures, and of known type). - In various embodiments, the
guide wire 14 and/or theflexible element 16 can be movable relative to thebody 12 in the longitudinal direction. - In various embodiments, the
flexible element 16 can be free to rotate around its own axis, thanks to a rotation system (not visible in the figures, and of known type) positioned at the proximal end of thecatheter 10. - In various embodiments, the
body 12 can have athird lumen 18c for sliding theguide wire 14. - In various embodiments, the three
lumen tubular sheath 122 can extend longitudinally within thebody 12 of the catheter and/or be independent of each other. - In various embodiments, the
body 12 of thecatheter 10 can have a diameter and a length so that they can be inserted into a blood vessel of the femoral region or of the brachial region of a human body, so as to carry the distal end of thecatheter 10 to the area where the administering of an active agent is required, for example to the heart (percutaneous insertion). - In various embodiments, as exemplified here, the
body 12 of the catheter can be created with a flexible material so that it can also be inserted into a tortuous blood vessel. - In various embodiments, a radiopaque element 171 (e.g. of platinum) can be associated with the distal end 2 of the
catheter 10, having the function of terminal marker to allow the operator - by means of scopy - to appropriately orient thecatheter 10 itself. - In various embodiments, the expandable portion (balloon) 22 can be used to stabilize the distal end 2 of the catheter in order to enable the
flexible element 16 to penetrate into the vessel wall to inject the active agent supplied through theconduit 18a. In various embodiments, theelement 16 is capable of acting by flexible needle (curvable) for administering, in practice by injecting it in the site to be treated (e.g. into a tissue lesion), the active agent (drug, reagent, etc.) supplied throughconduit 18a. - In various embodiments, this stabilizing function of the flexible element (needle) 16 can be conducted in addition to, or alternatively to, using the
balloon 22 for carrying out angioplasty. - As exemplified in
Figure 5 , in various embodiments, theflexible element 16 can comprise a (first) outertubular element 161 and a (second) inner or coretubular element 167 arranged within the firsttubular element 161 and capable of receiving the active agent to be administered from theconduit 18a. - In various embodiments, the outer
tubular element 161 can comprise a (super)elastic metallic material, such as Nitinol, while the inner or coretubular element 167 can comprise an flexible synthetic material (such as a polyamide resin or polyethylene). - In various embodiments, the first
tubular element 161 can be provided with, on a portion of its lateral surface, a sequence of notches orslots 163, capable of allowing theflexible element 16 to become curved with a jointed configuration, roughly definable as "spinal column-like." - In other words, in various embodiments, the first
tubular element 161 can comprise a plurality of open or closed sections or tubular segments ("vertebrae"), connected - at the bottom parts of the notches 163 - byflexible bridges 169 that enable bending of theelement 161 itself. - Regarding this, it will be appreciated, that even when - according to various embodiments - the
element 161 comprises a single piece of flexible material (e.g. an elastic or superelastic material such as nitinol), the tubular shape causes the aforementioned sections or segments to become rigid, or essentially rigid, with respect to bending in the longitudinal direction, and in any case, less flexible relative to thebridges 169 connecting them, thesebridges 169 identifying the regions of longitudinal bending of theelement 161. - In various embodiments, it is thus possible to ensure a general flexibility of the
element 161 even if the individual portions of this element (i.e. the "vertebrae" that form the element) included betweensuccessive notches 163 are themselves quite stiff. - In various embodiments, the first tubular element 161 (and therefore the
element 16 as a whole, thanks to the overall flexibility of the core element 167) can thus achieve, after extraction from thecatheter 10, an overall curved configuration in order to allow its penetration at the site (e.g. injured tissue) to be treated. - In various embodiments, the
flexible element 16 can present a sharp tip part (for example achamfer cut 165 at the distal opening of the first tubular element 161), capable of facilitating the penetration of theflexible element 16 into the treated site. - In various embodiments, the
notches 163 in the firsttubular element 161 can be produced by means of laser technology and/or can generally present a V-profile. - In various embodiments, the
notches 163 can be: - the same or different from each other, and/or
- distributed uniformly or non-uniformly with the possibility to establish, according to the requirements of use, the arcuate shape that the tubular element 161 (and the
element 16 as a whole) can assume after extraction from thebody 12 of the catheter. - In various embodiments, the
notches 163 can be, for example: - aligned along a side (a generatrix) of the
element 161 so as to be, when the element is curved, on the intrados of the arc of curvature or bending, - aligned along two sides or opposite generatices of the
element 161 so as to be, when the element is curved, in part on the intrados and in part on the extrados of the arc of curvature, and/or - variously distributed on the
element 161. - In various embodiments, the profile imparted to the notches 163 (e.g. the V-shaped opening angle imparted to them, where appropriate) may enable the determining of the final trajectory of curvature, which may be reached when the notches located on the intrados of the arc of curvature are "closed", with the opposite sides of the notch nearer to each other.
- In various embodiments, the secondo
tubular element 167, optionally continuous, can act as an internal core that closes thenotches 163 present on the firsttubular element 161; the active agent can then flow within theelement 16 to be released (injected) at the site to be treated, avoiding dispersion within the vessel (e.g. blood) where the catheter has been inserted. - In various embodiments, at least one
radiopaque element 170, e.g. platinum, can be associated with the flexible element 16 - for example by coupling it to the first tubular element 161 - with the function of trajectory marker of curvature to allow the operator - by means of scopy - to orient theflexible element 16 towards the lesion to be treated. - In various embodiments, the at least one trajectory marker of
curvature 170 can be placed alongside at least one of said notches, for example in correspondence with at least one of thebridges 169. - In various embodiments, a plurality of trajectory markers of
curvature 170 may be associated with theflexible element 16, and arranged alongside saidnotches 163. - In various embodiments, the flexible element 16 - straight or essentially straight when it is received within the
body 12 of the catheter - is therefore able, once extracted from the inner tubular sheath 122 (and therefore no longer contained radially by the innertubular sheath 122 itself), to become curved, or rather to take a general comma-shape. - In various embodiments, this result can be achieved, for example, when either one or the other, or both, of the outer
tubular element 161 and the innertubular element 167 presents the aforesaid curved conformation as "rest" configuration, or rather, a configuration where either one or the other, or both of theseelements tubular sheath 122 of the catheter. - In various embodiments, a similar result can be achieved, when either one or the other, or both, of the
outer element 161 and theinner element 167 present characteristics of shape-memory, activatable for example by administering energy (e.g. thermal or electrical) in order to carry theelement 16 into the curved condition for administering the active agent. In this case, the action of containment by the innertubular sheath 122 of the catheter in order to maintain theelement 16 in a straight condition, or essentially straight (not curved) may be unnecessary, so that it may be superfluous to envisage that theelement 16 is initially sheathed and then left uncovered when curving of theelement 16 is required. - In various embodiments, the structure and/or constituent materials exemplified herein allow a remote torsional control of the
element 16, starting from the proximal end of the catheter (kept outside the patient's body) so as to enable rotation of theflexible element 16 about the main axis of the distal portion of the catheter (e.g. the axis of the balloon 22) to ensure administration of the active agent at the treated site. - In various embodiments, this result can be achieved by rotating even just one of the
elements 161 or, respectively, 167 (having the capacity to curve - e.g. elastically and/or by shape-memory - in a determined direction) while theother element 167 or, respectively, 161 follows the first, thanks to a general flexibility. - In various embodiments, the roles of the
elements inner element 167, with theouter element 161 forming a sheath or flexible coat capable of wrapping the inner element, ensuring a seal at thenotches 163, which prevents leakage of the active agent through these notches. - In various embodiments, the method of use of the catheter exemplified here envisages that the
catheter 10 is introduced into the body of the patient according to current modes, for example, through the femoral artery, and guided until the distal portion is located at the site to be treated (by way of example, an area of the neo-infarcted heart). - The introduction of the catheter is carried out with the balloon in the radially-contracted condition (i.e. with the
balloon 22 "deflated", e.g. wrapped on the distal portion of the catheter). - Once the balloon has been carried to the treatment site, the inflation fluid is introduced under pressure into the
lumen 18b, causing theballoon 22 to inflate, expanding radially, for example as shown inFigure 5 , stabilizing the distal end of thecatheter 10. - The
flexible element 16 can be then made to exit from thebody 12 of the catheter, so that theelement 16 assumes, according to the criteria described above, the curved conformation exemplified in Part B ofFigure 5 . - In such conditions, the
element 16 can be oriented in such a way to allow it to penetrate into the site (e.g. tissue lesion) to be treated. The active agent is then supplied to theflexible element 16 through thelumen 18a, in order to carry out its function. - This can occur in a concomitant, or essentially concomitant, way with an angioplasty action resulting from the dilation of the
balloon 22, which may possibly be associated with an angioplasty stent in order to stabilize the stenosis. - The
catheter 10 described herein is usable for percutaneous procedures intended to reach not only the coronary arteries, but also all the reachable areas through the vascular system where it may be necessary to release an active agent, e.g. a drug to treat a lesion adjacent to a vessel. - The active agent (e.g. the drug) can be used either as an aqueous solution in order to enable a rapid absorption by the lesion, or as a colloidal dispersion (for example, a gel with a viscosity of up to 200-300 cP) for obtaining a slow and controlled release at the site to be treated.
- The stabilizing procedure of the distal portion of the catheter by the
balloon 22 can take into account possible critical aspects of blood flow in the area. For example for stabilizing the catheter in the coronary arteries, it is possible to limit the inflation time of the balloon so as not to induce undesired side effects of cardiac ischemia. - In other areas, where the blood flow is not critical, and the consequences of a temporary blockage of the blood circulation are better tolerated, it is possible to use greater inflation times.
- In various embodiments, the stabilizing
balloon 22 can be mounted on the distal part of the catheter so that its axis is not aligned with that of the catheter body, so as to favor the convergence of the flexible element to the vessel wall and, consequently, to the site to be treated. - In various embodiments, the system of reaching the position of release of the active agent can be configured as in the case for systems used for angioplasty, in which the tip of the catheter is directed with a guide catheter so that it can cross particular passages, such as the coronary ostia, with the catheter made to follow beyond the ostia up to the coronary artery, making it follow a guide wire that reaches the required point.
- Of course, without prejudice to the principle of the invention, the details of construction and the embodiments may be varied with respect to what is described and illustrated, without departing from the field of protection of the invention, this field of protection being defined by the attached claims.
Claims (12)
- A percutaneously-insertable catheter (10) for administering an active agent to a body site, the catheter comprising:- a distal portion (22) expandable from a contracted condition of introduction to a deployed administering condition, to stabilize the distal end (2) of the catheter (10) at said body site, and- a flexible tubular element (16) coupled to said distal end (2) of the catheter (10) for receiving the active agent and administering it to said body site, characterized in that:- the flexible element (16) comprises an outer tubular element (161) and an inner tubular element (167) inserted into the outer tubular element (161), with one (161) of said outer tubular element (161) and said inner tubular element (167) having notches (163) which enable spinal column-like curvature of the flexible element (16) towardssaid body site, and- the other (167) of said outer tubular element (161) and said inner tubular element (167) form a flexible sealing closure coat of the notches (163) present on one (161) of said outer tubular element (161) and said inner tubular element (167).
- A catheter according to claim 1, wherein the flexible element (16) presents a sharp distal end, preferably a chamfer cut (165) of the outer tubular element (161), capable of needle-like penetration into said body site.
- A catheter according to any one of the preceding claims, wherein said notches (163) have a V-shaped profile.
- A catheter according to any one of the preceding claims, wherein said notches (163) are aligned on one side of said one (161) of said outer tubular element (161) and said inner tubular element (167) so as to be situated on the intrados of the arc formed by said spinal column-like curvature.
- A catheter according to any one of the preceding claims, wherein the flexible element (16) comprises at least one marker element (170) to visualize said curvature by scopy.
- A catheter according to any one of the preceding claims, wherein the flexible element (16) comprises a plurality of marker elements (170) to visualize said curvature by scopy, wherein said marker elements (170) are localized at said notches (163).
- A catheter according to any one of the preceding claims, wherein said one (161) of said outer tubular element (161) and said inner tubular element (167) comprises a superelastic material, preferably nitinol.
- A catheter according to any one of the preceding claims, wherein said other (167) of said outer tubular element (161) and said inner tubular element (167) comprises a continuous tubular body of deformable material, preferably of plastic material.
- A catheter according to any one of the preceding claims, wherein said one (161) and said other (167) of said outer tubular element (161) and said inner tubular element (167) are, respectively, said outer tubular element (161) and said inner tubular element (167).
- A catheter according to any one of the preceding claims, wherein the flexible element (16) is coupled to said distal end (2) of the catheter (10), with the ability to move between a retracted position within the distal end (2) of the catheter (10) and an extracted position outside of the distal end (2) of the catheter (10).
- A catheter according to any one of the preceding claims, wherein at least one of the outer tubular element (161) and the inner tubular element (167) of the flexible element (16) is an elastic body having a curved rest configuration so that, in said extracted position outside of the distal end (2) of the catheter (10), the flexible element (16) elastically assumes a curved conformation.
- A catheter according to any one of the preceding claims, wherein at least one of the outer tubular element (161) and the inner tubular element (167) of the flexible element (16) is a body with shape-memory characteristics, which make it assume a curved conformation.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT000135A ITTO20130135A1 (en) | 2013-02-19 | 2013-02-19 | CATHETER FOR THE ADMINISTRATION OF ACTIVE AGENTS |
PCT/IB2014/059050 WO2014128608A1 (en) | 2013-02-19 | 2014-02-17 | Catheter for administering active agents |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2958615A1 EP2958615A1 (en) | 2015-12-30 |
EP2958615B1 true EP2958615B1 (en) | 2017-08-30 |
Family
ID=47953650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP14714351.5A Active EP2958615B1 (en) | 2013-02-19 | 2014-02-17 | Catheter for administering active agents |
Country Status (5)
Country | Link |
---|---|
US (1) | US20150297870A1 (en) |
EP (1) | EP2958615B1 (en) |
ES (1) | ES2646941T3 (en) |
IT (1) | ITTO20130135A1 (en) |
WO (1) | WO2014128608A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITUA20162094A1 (en) | 2016-03-29 | 2017-09-29 | Cid S P A | IMPROVEMENT IN STENTS FOR RELEASING ACTIVE PRINCIPLES |
CN111481813B (en) * | 2020-06-23 | 2020-09-29 | 上海明悦医疗科技有限公司 | Drug delivery device, method of manufacturing the same and drug delivery system |
EP4247467A1 (en) * | 2020-11-17 | 2023-09-27 | Junion Labs Pte. Ltd. | Drug delivery balloon catheter |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4235506A1 (en) | 1992-10-21 | 1994-04-28 | Bavaria Med Tech | Drug injection catheter |
US5693029A (en) | 1995-07-10 | 1997-12-02 | World Medical Manufacturing Corporation | Pro-cell intra-cavity therapeutic agent delivery device |
US20030069522A1 (en) * | 1995-12-07 | 2003-04-10 | Jacobsen Stephen J. | Slotted medical device |
EP0984790A1 (en) | 1997-06-02 | 2000-03-15 | Chiron Corporation | Herpes simplex virus vp22 vaccines and methods of use |
ATE353001T1 (en) * | 1999-05-11 | 2007-02-15 | Atrionix Inc | BALLOON ANCHORING WIRE |
US6692466B1 (en) * | 2000-12-21 | 2004-02-17 | Advanced Cardiovascular Systems, Inc. | Drug delivery catheter with retractable needle |
US20070219464A1 (en) * | 2002-03-22 | 2007-09-20 | Stephen Davis | Guidewire with deflectable re-entry tip |
WO2004045672A2 (en) * | 2002-11-15 | 2004-06-03 | The Government Of The United States As Represented By The Secretary Of The Department Of Health And Human Services | Variable curve catheter |
US7632242B2 (en) * | 2004-12-09 | 2009-12-15 | Boston Scientific Scimed, Inc. | Catheter including a compliant balloon |
US7402151B2 (en) * | 2004-12-17 | 2008-07-22 | Biocardia, Inc. | Steerable guide catheters and methods for their use |
EP2004072B1 (en) * | 2006-04-13 | 2013-09-11 | Cook Medical Technologies LLC | Apparatus for endoscopic resection of tissue |
US20070282257A1 (en) | 2006-06-05 | 2007-12-06 | Schatz Richard A | Myocardial injector with balloon abutment |
US8979803B2 (en) * | 2007-04-05 | 2015-03-17 | Allan J. Darr | Stylet for bilumenal flexible medical device |
US20090131867A1 (en) * | 2007-11-16 | 2009-05-21 | Liu Y King | Steerable vertebroplasty system with cavity creation element |
WO2010024871A1 (en) | 2008-08-26 | 2010-03-04 | Med Institute, Inc. | Balloon catheters having a plurality of needles for the injection of one or more therapeutic agents |
US20100069882A1 (en) * | 2008-09-18 | 2010-03-18 | Boston Scientific Scimed, Inc. | Medical device with preferential bending |
US20100082051A1 (en) * | 2008-09-19 | 2010-04-01 | Thorpe Patricia E | Vascular occlusion drill |
BE1018521A5 (en) * | 2009-04-29 | 2011-02-01 | Cardio3 Biosciences Sa | INJECTION CATHETER FOR DELIVERING A THERAPEUTIC AGENT IN A SUBSTRATE. |
US9039676B2 (en) * | 2009-06-11 | 2015-05-26 | St. Jude Medical Puerto Rico Llc | Apparatus and methods for catheter steerability |
US20110190831A1 (en) * | 2010-01-29 | 2011-08-04 | Kyphon Sarl | Steerable balloon catheter |
CN106422025B (en) * | 2011-05-03 | 2020-09-04 | 卡里拉医疗股份有限公司 | Steerable delivery sheath |
DE102012214872B4 (en) | 2012-08-22 | 2015-02-26 | Schaeffler Technologies Gmbh & Co. Kg | ABS encoder arrangement |
-
2013
- 2013-02-19 IT IT000135A patent/ITTO20130135A1/en unknown
-
2014
- 2014-02-17 US US14/648,841 patent/US20150297870A1/en not_active Abandoned
- 2014-02-17 WO PCT/IB2014/059050 patent/WO2014128608A1/en active Application Filing
- 2014-02-17 ES ES14714351.5T patent/ES2646941T3/en active Active
- 2014-02-17 EP EP14714351.5A patent/EP2958615B1/en active Active
Non-Patent Citations (1)
Title |
---|
None * |
Also Published As
Publication number | Publication date |
---|---|
ITTO20130135A1 (en) | 2014-08-20 |
EP2958615A1 (en) | 2015-12-30 |
US20150297870A1 (en) | 2015-10-22 |
ES2646941T3 (en) | 2017-12-18 |
WO2014128608A1 (en) | 2014-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7093744B2 (en) | Perivascular tissue ablation catheter with support structure | |
JP6932037B2 (en) | Catheter system for vascular wall injection and perivascular renal denervation | |
US20240050703A1 (en) | Augmented delivery catheter and method | |
US10143824B2 (en) | Catheter assemblies and methods for stabilizing a catheter assembly within a subintimal space | |
US9636486B2 (en) | Methods and devices for eluting agents to a vessel | |
US7273469B1 (en) | Modified needle catheter for directional orientation delivery | |
US9126016B2 (en) | Augmented delivery catheter and method | |
EP2898920B1 (en) | Articulating balloon catheter | |
US20070250035A1 (en) | Devices and methods for intravascular drug delivery | |
US20100261662A1 (en) | Utilization of mural thrombus for local drug delivery into vascular tissue | |
JP2010537680A (en) | Minimally invasive endovascular treatment device | |
JP2013537460A (en) | Medical implant delivery device tip | |
EP3740272A1 (en) | Injection port for therapeutic delivery | |
EP2958615B1 (en) | Catheter for administering active agents | |
US20200261695A1 (en) | Therapeutic agent delivery system with delayed activation | |
CN109701140B (en) | Balloon catheter and puncture system thereof | |
CN215822075U (en) | Power-gathering drug-loading balloon dilatation catheter | |
US20230025500A1 (en) | System and method for selective pressure-controlled therapeutic delivery | |
EP2065069A1 (en) | A Catheter based Medical Device and Method for Delivery of a Therapeutic Agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20150423 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61M 25/10 20130101ALI20170421BHEP Ipc: A61M 25/04 20060101ALI20170421BHEP Ipc: A61M 25/00 20060101AFI20170421BHEP |
|
INTG | Intention to grant announced |
Effective date: 20170517 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 922958 Country of ref document: AT Kind code of ref document: T Effective date: 20170915 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602014013798 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ISLER AND PEDRAZZINI AG, CH |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2646941 Country of ref document: ES Kind code of ref document: T3 Effective date: 20171218 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MP Effective date: 20170830 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 5 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 922958 Country of ref document: AT Kind code of ref document: T Effective date: 20170830 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: HR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: NO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171230 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171130 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20171201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: SM Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602014013798 Country of ref document: DE |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20180531 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 |
|
REG | Reference to a national code |
Ref country code: BE Ref legal event code: MM Effective date: 20180228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20180217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 Ref country code: MK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20170830 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20140217 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170830 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20221209 Year of fee payment: 10 Ref country code: FR Payment date: 20221208 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20230310 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: TR Payment date: 20230216 Year of fee payment: 10 Ref country code: IT Payment date: 20230110 Year of fee payment: 10 |
|
P01 | Opt-out of the competence of the unified patent court (upc) registered |
Effective date: 20230531 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240227 Year of fee payment: 11 Ref country code: CH Payment date: 20240301 Year of fee payment: 11 Ref country code: GB Payment date: 20240222 Year of fee payment: 11 |